| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205
Th1 cells exposed to Ag and the G1 blocker n-butyrate in primary cultures lose their ability to proliferate in Ag-stimulated secondary cultures. The ability of n-butyrate to induce anergy in Ag-stimulated, but not resting, Th1 cells was shown here to be blocked by cycloheximide. Subsequent experiments to delineate the nature of the protein apparently required for n-butyrate-induced Th1 cell anergy focused on the role of cyclin-dependent kinase (cdk) inhibitors p21Cip1 and p27Kip1. Normally, entry into S phase by Th1 cells occurs around 24 h after Ag stimulation and corresponds with relatively low levels of both p21Cip1 and p27Kip1. However, unlike control Th1 cells, anergic Th1 cells contained high levels of both p21Cip1 and p27Kip1 when examined 24 h after Ag stimulation. The increase in p21Cip1 observed in Ag-stimulated anergic Th1 cells appeared to be initiated in primary cultures. In contrast, the increase in p27Kip1 observed in these anergic Th1 cells appears to represent a re-expression of the protein much earlier than control cells following Ag stimulation in secondary cultures. The anergic Th1 cells contained functionally active cdk inhibitors capable of inhibiting the activity of both endogenous and exogenous cdks. Consequently, it appears that n-butyrate-induced anergy in Th1 cells correlated with the up-regulation of p21Cip1 and perhaps the downstream failure to maintain low levels of p27Kip1. Increased levels of both p21Cip1 and p27Kip1 at the end of G1 could prevent cdk-mediated entry into S phase, and thus help maintain the proliferative unresponsiveness found in the anergic Th1 cells.
This article has been cited by other articles:
|
|
 |
|
  M. A. Kriegel, S. Adam-Klages, C. Gabler, N. Blank, M. Schiller, C. Scheidig, J. R. Kalden, and H.-M. Lorenz Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy Int. Immunol., April 1, 2008; 20(4): 601 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zheng, S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole, P. E. Zarek, and J. D. Powell A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy J. Immunol., February 15, 2007; 178(4): 2163 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kreijveld, H. J. P. M. Koenen, L. B. Hilbrands, H. J. P. van Hooff, and I. Joosten The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25- T cells Blood, January 1, 2007; 109(1): 244 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rowell, L. Wang, W. W. Hancock, and A. D. Wells The Cyclin-Dependent Kinase Inhibitor p27kip1 Is Required for Transplantation Tolerance Induced by Costimulatory Blockade J. Immunol., October 15, 2006; 177(8): 5169 - 5176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Khanna, M. Plummer, V. Nilakantan, and G. M. Pieper Recombinant p21 Protein Inhibits Lymphocyte Proliferation and Transcription Factors J. Immunol., June 15, 2005; 174(12): 7610 - 7617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rowell, M. C. Walsh, and A. D. Wells Opposing Roles for the Cyclin-Dependent Kinase Inhibitor p27kip1 in the Control of CD4+ T Cell Proliferation and Effector Function J. Immunol., March 15, 2005; 174(6): 3359 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, J. Domenico, J. J. Lucas, and E. W. Gelfand Identification of Multiple Cell Cycle Regulatory Functions of p57Kip2 in Human T Lymphocytes J. Immunol., August 15, 2004; 173(4): 2383 - 2391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Adams, A. M. Grierson, A. M. Mowat, M. M. Harnett, and P. Garside Differences in the Kinetics, Amplitude, and Localization of ERK Activation in Anergy and Priming Revealed at the Level of Individual Primary T Cells by Laser Scanning Cytometry J. Immunol., August 1, 2004; 173(3): 1579 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Allen, Y. Zheng, L. Gardner, M. Safford, M. R. Horton, and J. D. Powell The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction J. Immunol., April 15, 2004; 172(8): 4797 - 4803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Colombetti, F. Benigni, V. Basso, and A. Mondino Clonal Anergy Is Maintained Independently of T Cell Proliferation J. Immunol., December 1, 2002; 169(11): 6178 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Asai, S. Hachimura, M. Kimura, T. Toraya, M. Yamashita, T. Nakayama, and S. Kaminogawa T Cell Hyporesponsiveness Induced by Oral Administration of Ovalbumin Is Associated with Impaired NFAT Nuclear Translocation and p27kip1 Degradation J. Immunol., November 1, 2002; 169(9): 4723 - 4731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lunemann, S. Waiczies, S. Ehrlich, U. Wendling, B. Seeger, T. Kamradt, and F. Zipp Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells J. Immunol., May 15, 2002; 168(10): 4881 - 4888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Saemann, O. Parolini, G. A. Bohmig, P. Kelemen, P.-M. Krieger, J. Neumuller, K. Knarr, W. Kammlander, W. H. Horl, C. Diakos, et al. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells J. Leukoc. Biol., February 1, 2002; 71(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D Dick, V. Sharma, and J. Liversidge Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy Br. J. Ophthalmol., August 1, 2001; 85(8): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
